Related references
Note: Only part of the references are listed.Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
Olga Martinho et al.
PLOS ONE (2012)
Additive Effect on Survival of Raf Kinase Inhibitor Protein and Signal Transducer and Activator of Transcription 3 in High-Grade Glioma
Judith Maresch et al.
CANCER (2011)
Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer
Jieun Yun et al.
EMBO JOURNAL (2011)
PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection
Yong-Feng Xu et al.
JOURNAL OF HEPATOLOGY (2010)
Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma
Hyun-Soo Kim et al.
PATHOLOGY (2010)
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
N. M. Alajez et al.
CELL DEATH & DISEASE (2010)
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Jason T. Huse et al.
NATURE REVIEWS CANCER (2010)
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7
Surabhi Dangi-Garimella et al.
EMBO JOURNAL (2009)
HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma
Alexandra C. Hristov et al.
MODERN PATHOLOGY (2009)
Loss of RKIP expression is associated with poor survival in GISTs
Olga Martinho et al.
VIRCHOWS ARCHIV (2009)
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor
Alexey E. Granovsky et al.
CELL RESEARCH (2008)
Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction
Jan Klysik et al.
CELLULAR SIGNALLING (2008)
Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome
Devasis Chatterjee et al.
CLINICAL CANCER RESEARCH (2008)
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 MicroRNA family
Kazuo Motoyama et al.
CLINICAL CANCER RESEARCH (2008)
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
Gennaro Chiappetta et al.
EUROPEAN JOURNAL OF CANCER (2008)
Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target
Lingchun Zeng et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
HMGA2 gene is a promising target for ovarian cancer silencing therapy
Anastasia Malek et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment
Dominique B. Hoelzinger et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Diffuse glioma growth: a guerilla war
An Claes et al.
ACTA NEUROPATHOLOGICA (2007)
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion
Anita B. Hjelmeland et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations
Judith Jeuken et al.
ACTA NEUROPATHOLOGICA (2007)
HMGA2 overexpression in non-small cell lung cancer
Britta Meyer et al.
MOLECULAR CARCINOGENESIS (2007)
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
Carla Hebert et al.
MOLECULAR CANCER (2007)
MicroRNA and cancer: Current status and prospective
Wei Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration
Liat Goldberg et al.
CANCER RESEARCH (2006)
Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines
Jia Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Essential role for Ras signaling in glioblastoma maintenance
SL Holmen et al.
CANCER RESEARCH (2005)
The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein
ET Keller et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity
J Miyazawa et al.
CANCER RESEARCH (2004)
The role of Raf kinase inhibitor protein (RKIP) in health and disease
ET Keller et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines
MM Schuierer et al.
CANCER RESEARCH (2004)
Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP)
ET Keller
ANTI-CANCER DRUGS (2004)
Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis
Z Fu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Share Paper
